David Sinclair· PhD
Thus, NAD boosters should be investigated as a therapeutic for preserving bone health, especially in obese and diabetic individuals
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Thus, NAD boosters should be investigated as a therapeutic for preserving bone health, especially in obese and diabetic individuals
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
The NAD booster nicotinamide riboside (NR) reverses insulin resistance & improves bone density in diabetic mice.